Article info

Download PDFPDF
Safety of 5914 intravitreal ziv-aflibercept injections


  1. Correspondence to Dr Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Hyderabad 500034, India; jay.chhablani{at}
View Full Text


Singh SR, Stewart MW, Chattannavar G on behalf of the Ziv-aflibercept Study Group, et al
Safety of 5914 intravitreal ziv-aflibercept injections

Publication history

  • Received May 13, 2018
  • Revised June 11, 2018
  • Accepted July 2, 2018
  • First published August 11, 2018.
Online issue publication 
May 28, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.